Abstract
The human body is actually a vast and changing ecosystem comprised of billions of microbial organisms, known collectively as the microbiome. Within the last few years, the study of the microbiome and its impact on human health has been a rapidly growing area of biomedical science. The gut intestinal tract microbiome has been a particular focus of research given its potential role in many inflammatory and metabolic diseases as well as drug metabolism. Although a nascent field, the potential for modulating the gut microbiome or human host interactions associated with these microbes offers new therapeutic strategies for many chronic diseases, in particular obesity, diabetes and inflammatory bowel diseases. Here we provide an overview of present knowledge about the gut microbiome, its putative role in metabolic diseases and the potential for microbiome focused treatments from the drug development perspective.
References
1.
Kiley J.P.
(2011 ) Chest , 140 , 497 –501 .
2.
Danielsson D.
2011 ) Ann. N. Y. Acad. Sci. , 1230 , 48 –58 .
3.
Sekirov I.
2010 ) Physiol. Rev. , 90 , 859 –904 .
4.
Grice E.A.
, and
Segre J.A.
(2011 ) Nat. Rev. Microbiol. , 9 , 244 –253 .
5.
Ley R.E.
2006 ) Cell , 124 , 837 –848 .
6.
Savage D.C.
(1977 ) Annu. Rev. Microbiol. , 31 , 107 –133 .
7.
Qin J.
2012 ) Nature , 490 , 55 –60 .
8.
Whitman W.B.
1998 ) Proc. Natl. Acad. Sci. USA , 95 , 6578 –6583 .
9.
Wikoff W.R.
2009 ) Proc. Natl. Acad. Sci. USA , 106 , 3698 –3703 .
10.
O'Hara A.M.
, and
Shanahan F.
(2007 ) Gut microbiota: mining for therapeutic potential . Clin. Gastroenterol. Hepatol. , 5 , 274 –284 .
11.
Sparo M.
2012 ) Lett. Appl. Microbiol. , 54 , 119 –125 .
12.
Wu G.D.
2011 ) Science , 334 , 105 –108 .
13.
Turnbaugh P.J.
, and
Gordon J.I.
(2009 ) J. Physiol. , 587 , 4153 –4158 .
14.
Arumugam M.
2011 ) Nature , 473 , 174 –180 .
15.
Qin J.
2010 ) Nature , 464 , 59 –65 .
16.
Turnbaugh P.J.
2009 ) Nature , 457 , 480 –484 .
17.
Jeffery I.B.
2012 ) Nat. Rev. Microbiol. , 10 , 591 –592 .
18.
De F.C.
2010 ) Proc. Natl. Acad. Sci. USA , 107 , 14691 –14696 .
19.
Dominguez-Bello M.G.
2010 ) Proc. Natl. Acad. Sci. USA , 107 , 11971 –11975 .
20.
Hehemann J.H.
2010 ) Nature , 464 , 908 –912 .
21.
O'Brien P.E.
(2010 ) J. Gastroenterol. Hepatol. , 25 , 1358 –1365 .
22.World Health Organization: Obesity and overweight–Fact sheet N°311 , May 2012 (http://www.who.int/mediacentre/factsheets/fs311/en/index.html).
23.
Finkelstein E.A.
2009 ) Health Aff. (Millwood.) , 28 , w822 –w831 .
24.
Backhed F.
2004 ) Proc. Natl. Acad. Sci. USA , 101 , 15718 –15723 .
25.
Turnbaugh P.J.
2006 ) Nature , 444 , 1027 –1031 .
26.
Turnbaugh P.J.
2008 ) Cell Host. Microbe , 3 , 213 –223 .
27.
Ley R.E.
2006 ) Nature , 444 , 1022 –1023 .
28.
Cani P.D.
, and
Delzenne N.M.
(2011 ) Pharmacol. Ther. , 130 , 202 –212 .
29.
Xu P.
2012 ) BMC. Microbiol. , 12 , 283 .
30.
Armougom F.
2009 ) PLoS. One , 4 , e7125 .
31.
Collado M.C.
2008 ) Am. J. Clin. Nutr. , 88 , 894 –899 .
32.
Duncan S.H.
2008 ) Int. J. Obes. (Lond) , 32 , 1720 –1724 .
33.
Mai V.
2009 ) Nutr. J. , 8 , 49 .
34.
Derosa G.
, and
Maffioli P.
(2012 ) Expert. Opin. Drug Saf. , 11 , 459 –471 .
35.
Wong D.
2012 ) Nat. Rev. Drug Discov. , 11 , 669 –670 .
36.
O'Neil P.M.
2012 ) Obesity. (Silver. Spring) , 20 , 1426 –1436 .
37.
Kaplan L.M.
(2010 ) Gastroenterol. Clin. North Am. , 39 , 69 –79 .
38.
Hullar M.A.
, and
Lampe J.W.
(2012 ) Nestle. Nutr. Inst. Workshop Ser. , 73 , 67 –79 .
39.
Aron-Wisnewsky J.
2012 ) Nat. Rev. Gastroenterol. Hepatol. , 9 , 590 –598 .
40.
Cani P.D.
(2012 ) Clin. Microbiol. Infect. Suppl. 4 , 18 , 50 –53 .
41.
Cani P.D.
2012 ) Gut Microbes , 3 , 279 –288 .
42.
Williams S.
2012 ) Med. Princ. Pract. , 21 , 301 –309 .
43.
Pories W.J.
1995 ) Ann. Surg. , 222 , 339 –350 .
44.
Stefater M.A.
2012 ) Endocr. Rev. , 33 , 595 –622 .
45.
Greenway F.L.
, and
Bray G.A.
(2010 ) Curr. Diab. Rep. , 10 , 108 –115 .
46.
Tam C.S.
2011 ) Obes. Rev. , 12 , 984 –994 .
47.
Jeppsson B.
2011 ) Nutrients , 3 , 604 –612 .
48.
Li J.V.
2011 ) Gut , 60 , 1214 –1223 .
49.
Zhang H.
2009 ) Proc. Natl. Acad. Sci. USA , 106 , 2365 –2370 .
50.
Furet J.P.
2010 ) Diabetes , 59 , 3049 –3057 .
51.
Graessler J.
2012 ) Pharmacogenomics. J. , doi: 10.1038/tpj.2012.43 [Epub ahead of print].
52.
Murphy E.F.
, and
Quigley E.M.
(2012 ) Gastroenterology , 142 , 399 –401 .
53.
Cani P.D.
, and
Delzenne N.M.
(2010 ) Acta Gastroenterol. Belg. , 73 , 267 –269 .
54.
Larsen N.
2010 ) PLoS. One. , 5 , e9085 .
55.
Henao-Mejia J.
2012 ) Nature , 482 , 179 –185 .
56.
Thuny F.
2010 ) PLoS. One , 5 , e9074 .
57.
Nicholson J.K.
2012 ) Science , 336 , 1262 –1267 .
58.
Hooper L.V.
, and
Macpherson A.J.
(2010 ) Nat. Rev. Immunol. , 10 , 159 –169 .
59.
Wells J.M.
2011 ) E. Proc. Natl. Acad. Sci. USA, Suppl. 1 , 108 , 4607 –4614 .
60.
Hviid A.
2011 ) Gut , 60 , 49 –54 .
61.
Shaw S.Y.
2011 ) Am. J. Gastroenterol. , 106 , 2133 –2142 .
62.
Round J.L.
, and
Mazmanian S.K.
(2009 ) Nat. Rev. Immunol. , 9 , 313 –323 .
63.
Abraham C.
, and
Medzhitov R.
(2011 ) Gastroenterology , 140 , 1729 –1737 .
64.
Willing B.P.
2010 ) Gastroenterology , 139 , 1844 –1854 .
65.
Jostins L.
2012 ) Nature , 491 , 119 –124 .
66.
Marchesi J.R.
2011 ) PLoS. One , 6 , e20447 .
67.
Sobhani I.
2011 ) PLoS. One , 6 , e16393 .
68.
Li Y.
2012 ) Carcinogenesis , 33 , 1231 –1238 .
69.
Arthur J.C.
2012 ) Science , 338 , 120 –123 .
70.
McLoughlin R.M.
, and
Mills K.H.
(2011 ) J. Allergy Clin. Immunol. , 127 , 1097 –1107 .
71.
Cryan J.F.
, and
Dinan T.G.
(2012 ) Nat. Rev. Neurosci. , 13 , 701 –712 .
72.
Lyte M.
(2011 ) Bioessays , 33 , 574 –581 .
73.
Bravo J.A.
2011 ) Proc. Natl. Acad. Sci. USA , 108 , 16050 –16055 .
74.
Ming X.
2012 ) J. Proteome. Res. , 11 , 5856 –5862 .
75.
Weinstock J.V.
, and
Elliott D.E.
(2009 ) Inflamm. Bowel. Dis. , 15 , 128 –133 .
76.
Elliott D.E.
, and
Weinstock J.V.
(2009 ) Adv. Exp. Med. Biol. , 666 , 157 –166 .
77.
Preidis G.A.
2012 ) FASEB. J. , 26 , 1960 –1969 .
78.
Preidis G.A.
, and
Versalovic J.
(2009 ) Gastroenterology , 136 , 2015 –2031 .
79.
Shanahan F.
2012 ) Clin. Gastroenterol. Hepatol. , 10 , 1220 –1224 .
80.
Quigley E.M.
(2011 ) Curr. Opin. Pharmacol. , 11 , 593 –603 .
81.
Hickson M.
2007 ) BMJ , 335 , 80 .
82.
Atarashi K.
2011 ) Science , 331 , 337 –341 .
83.
Arslanoglu S.
2007 ) J. Nutr. , 137 , 2420 –2424 .
84.
Bailey J.R.
2011 ) PLoS. One. , 6 , e26507 .
85.
Landy J.
2011 ) Aliment. Pharmacol. Ther. , 34 , 409 –415 .
86.
Borody T.J.
, and
Campbell J.
(2012 ) Gastroenterol. Clin. North Am. , 41 , 781 –803 .
87.
Dethlefsen L.
2008 ) PLoS. Biol. , 6 , e280 .
88.
Blaser M.
(2011 ) Nature , 476 , 393 –394 .
89.
Proal A.D.
2011 ) Cell Mol. Immunol. , 8 , 213 –225 .
90.
Kootte R.S.
2012 ) Diabetes Obes. Metab. , 14 , 112 –120 .
91.
Payne D.J.
2007 ) Nat. Rev. Drug Discov. , 6 , 29 –40 .
92.
Eckburg P.B.
2005 ) Science , 308 , 1635 –1638 .
93.
Feria-Gervasio D.
2011 ) Appl. Microbiol. Biotechnol. , 91 , 1425 –1433 .
94.
Kim H.J.
2012 ) Lab Chip. , 12 , 2165 –2174 .
95.
Ellrott K.
2010 ) PLoS. Comput. Biol. , 6 , e1000798 .
96.
Zaneveld J.
2008 ) Curr. Opin. Chem. Biol. , 12 , 109 –114 .
97.
Saleh M.
, and
Trinchieri G.
(2011 ) Nat. Rev. Immunol. , 11 , 9 –20 .
98.
Knight P.
2008 ) Br. Med. Bull. , 88 , 95 –113 .
99.
Shenderov B.A.
(2011 ) Anaerobe , 17 , 490 –495 .
100.
Bernardo D.
2012 ) PLoS. One , 7 , e36262 .
101.
Sousa T.
2008 ) Int. J. Pharm. , 363 , 1 –25 .
102.
Okuda H.
1998 ) J. Pharmacol. Exp. Ther. , 287 , 791 –799 .
103.
Wallace B.D.
2010 ) Science , 330 , 831 –835 .
104.
Alimonti A.
2003 ) Ann. Oncol. , 14 , 805 –806 .
105.
Kaddurah-Daouk R.
2011 ) PLoS. One , 6 , e25482 .
106.
Nicholson J.K.
2011 ) Pharmacogenomics , 12 , 103 –111 .